Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3149)	4/16/2011 10:38:48 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ABMD has also done well and continued its UT without closing the FEB UG in spite of persistent insider selling.<g> bigcharts.marketwatch.com But ABMD has negligible LTD, it has +CF and pretty good institutional following. The insiders hold around 16% and institutions > 70% of the float. The short ratio is around 9 and the short position increased some in the last month. Although the ACTAY is $14.69 it seems that with some short covering, the stock could get to the $20 level in spite of the insider selling.<g> bigcharts.marketwatch.com Bernard